(19)
(11) EP 0 673 248 A1

(12)

(43) Date of publication:
27.09.1995 Bulletin 1995/39

(21) Application number: 94902046.0

(22) Date of filing: 08.12.1993
(51) International Patent Classification (IPC): 
C07D 313/ 08( . )
A61K 31/ 275( . )
A61K 31/ 38( . )
A61P 25/ 08( . )
A61P 25/ 28( . )
C07C 233/ 65( . )
A61K 31/ 00( . )
A61K 31/ 335( . )
A61P 25/ 00( . )
A61P 25/ 18( . )
A61P 25/ 30( . )
(86) International application number:
PCT/GB1993/002514
(87) International publication number:
WO 1994/013292 (23.06.1994 Gazette 1994/14)
(84) Designated Contracting States:
BE CH DE ES FR GB IT LI NL

(30) Priority: 11.12.1992 GB 19920025860

(71) Applicants:
  • SMITHKLINE BEECHAM PLC
    Brentford, Middlesex TW8 9EP (GB)
  • SMITHKLINE BEECHAM CORPORATION
    Philadelphia Pennsylvania 19103 (US)

(72) Inventors:
  • VONG, Kuok Keong, SmithKline Beecham Pharmacs.
    Essex CM19 5AD (GB)
  • EVANS, John Morris, SmithKline Beecham Pharmacs.
    Essex CM19 5AD (GB)
  • NADLER, Guy M.M.G., SmithKline Beecham Lab.Pharma
    F-35762 Saint-GrĂ©goire (FR)
  • WILLETTE, Robert Nicholas
    King of Prussia, PA 19406-2799 (US)

(74) Representative: Lawton, Peter Philip, et al 
SmithKline Beecham, Corporate Intellectual Property, SB House, Great West Road
Brentford, Middlesex TW8 9BD
Brentford, Middlesex TW8 9BD (GB)

   


(54) POTASSIUM CHANNEL ACTIVATORS FOR USE IN THERAPY